# |
PMID |
Sentence |
1 |
10845721
|
Chimeric forms of IL-4 with the type I transmembrane protein CD4 or type II transmembrane protein TNF were designed to express IL-4 in opposite orientations on the tumor cell surface.
|
2 |
10845721
|
Expression of the IL-4/TNF chimeric protein on MethA cells elicited antitumor immunity and protected from MethA tumor challenge.
|
3 |
25117071
|
The CD40 ligand is a type I transmembrane protein that belongs to a tumor necrosis factor (TNF) superfamily.
|
4 |
25117071
|
The receptor for ligand is constitutively expressed on cells, TNF family protein: CD40.
|
5 |
25117071
|
The role of the CD40/CD40L pathway in the induction of body immunity, in inflammation, or in hemostasis has been well documented, whereas its involvement in neoplastic disease is still under investigation.
|
6 |
25117071
|
CD40L ligand may potentiate apoptosis of tumor cells by activation of nuclear factor-κB (NF-κB), AP-1, CD95, or caspase-depended pathways and stimulate host immunity to defend against cancer.
|
7 |
25117071
|
CD40L enhance release of strongly pro-angiogenic factor, vascular endothelial growth factor (VEGF), and activator of coagulation, TF, the level of which is correlated with tumor metastasis.
|